Newsroom

LYON, Francia--(BUSINESS WIRE)--Brenus Pharma, una empresa de biotecnología en fase clínica pionera en inmunoterapias «listas para su uso» in vivo, ha anunciado la selección de un resumen para su presentación en póster en la conferencia anual de la American Association for Cancer Research Immuno-Oncology (AACRIO) (del 18 al 21 de febrero de 2026), en Los Ángeles. El póster muestra nuevos datos preclínicos y los primeros resultados clínicos del principal producto en desarrollo de la empresa, el...

LYON, France--(BUSINESS WIRE)--Brenus Pharma, une société de biotechnologie au stade clinique pionnière dans le domaine des immunothérapies in vivo « prêtes à l’emploi », a annoncé la sélection d’un résumé pour une présentation par affiche lors de la conférence annuelle de l’American Association for Cancer Research Immuno-Oncology (AACRIO) (du 18 au 21 février 2026) à Los Angeles. Le poster présente de nouvelles données précliniques et les premiers résultats cliniques du principal candidat de l...

LYON, Frankreich--(BUSINESS WIRE)--Brenus Pharma, ein Biotechnologieunternehmen mit Schwerpunkt auf der klinischen Forschung und Wegbereiter für gebrauchsfertige In-vivo-Immuntherapien, gab bekannt, dass ein Abstract für eine Posterpräsentation bei der diesjährigen Jahrestagung der American Association for Cancer Research Immuno-Oncology (AACRIO) (18. bis 21. Februar 2026) in Los Angeles ausgewählt wurde. Das Poster stellt neue präklinische Daten und erste klinische Ergebnisse zum führenden Wir...

LIONE, Francia--(BUSINESS WIRE)--Brenus Pharma, una società biotecnologica di fase clinica all'avanguardia nell'ambito delle immunoterapie in vivo pronte all'uso, ha annunciato la selezione di un abstract per una presentazione poster in occasione della conferenza annuale American Association for Cancer Research Immuno-Oncology (AACRIO) (18-21 febbraio 2026) a Los Angeles. Il poster presenta i nuovi dati preclinici e le informazioni cliniche iniziali ottenute dal principale candidato dell'aziend...

MONTEVIDEO, Uruguay--(BUSINESS WIRE)--Arcos Dorados Holdings Inc. (NYSE: ARCO) will hold a webcast to discuss its results for the fourth quarter and full year ended December 31, 2025, which will be released before the market opens on Thursday, March 19, 2026. Luis Raganato, Chief Executive Officer, and senior management will host the webcast. Opening remarks will be followed by a question-and-answer period. Participants from the investment community will be able to join the webcast (Google Chro...

LONDON--(BUSINESS WIRE)--Endava plc (NYSE: DAVA) ("Endava" or the "Company"), the technology-driven business transformation group whose AI-native approach combines cutting edge technology with deep industry expertise, today announced results for the three months ended December 31, 2025 ("Q2 FY2026"). "Over the past several quarters we have been investing heavily in our pivot towards AI to establish Endava as an AI leader. These investments have encompassed recruitment and training of NextGen Ta...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share FIRST TRUST BLOOMBERG GLOBAL SEMICONDUCTOR SUPPLY CHAIN UCITS ETF 18.02.2026 CHPS.LN IE000KXTLDE2 700,002.00 USD 25,713,352.54 36.733  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Indxx Global Aerospace & Defence UCITS ETF 18.02.2026 MISL.LN IE000NVDQXE1 3,375,002.00 USD 125,311,833.12 37.129  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest Nasdaq-100 Moderate Buffer UCITS ETF - September 18.02.2026 QSEP.LN IE000FQ808R5 450,002.00 USD 10,263,674.32 22.808  ...

CARLSBAD, Calif.--(BUSINESS WIRE)--Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that management will participate in fireside chats at the following investor conferences: Oppenheimer 36th Annual Healthcare Life Sciences Virtual Conference on Thursday, February 26, 2026 TD Cowen 46th Annual Health Care Conference on Monday, March 2, 2026 Leerink Global Healthcare Conference on Monday, March 9, 2026 Barclays 28th Annual Global Healthcare Conference on Wednesday, March 11, 2026 Stifel...